Cara Therapeutics | Omløpsmidler

Current Assets Endring Dato
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Cassava Sciences USD 150.18M 24.35M 2023-09
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Grifols EUR 5.02B 210.6M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pacira USD 509.99M 62.74M 2023-12
Pfizer USD 74.01B 665M 2023-09
RedHill Biopharma USD 27.05M 19.47M 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12



Cara Therapeutics Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.